Skip to content

Member

Adam JARUBAS

EPP · Poland

Group
EPP PPE
Country
Poland
Roll-call participation
76.9 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
95.0 %ⓘ of 477 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
PSL Polskie Stronnictwo Ludowe
In office
Since 16 Jul 2024
Against clear line
14 of 452 votesⓘ
Committees
ENVI (substitute), ITRE, SANT (chair)
Member id
197517
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

76.9 %

477 of 620 final votes while in office

EPP median: 90.6 % (−13.6 pts)

Chamber median: 90.6 %

With majority line ⓘ

95.0 %

453 of 477 votes where their group had a line

EPP median: 95.6 % (−0.6 pts)

Against clear line ⓘ

3.1 %

14 of 452 votes where their group had a clear line

8 opposite (for ↔ against), 6 abstained against the line

Abstention ⓘ

2.3 %

11 of 477 votes cast

Participation 76.9 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
Adam JARUBAS76.9 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 95.0 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
Adam JARUBAS95.0 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
29 Apr 2026Discharge 2024: European Public Prosecutor’s Office Discharge decision adopted 454 for, 161 against, 29 abstainedPosition: For Majority line: For
29 Apr 2026Discharge 2024: Agencies Discharge decision adopted 475 for, 107 against, 71 abstainedPosition: For Majority line: For
29 Apr 2026Discharge 2024: Joint Undertakings Discharge decision adopted 525 for, 104 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/008 BE/Liberty - Belgium Passed 586 for, 48 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Genetically modified soybean MON 94637 Objection passed 412 for, 145 against, 11 abstainedPosition: Against Majority line: Against
29 Apr 2026Situation of fundamental rights in the European Union in 2024 and 2025 Adopted 328 for, 199 against, 98 abstainedPosition: Abstained Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Adopted 387 for, 191 against, 46 abstainedPosition: For Majority line: For
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Adopted 416 for, 190 against, 15 abstainedPosition: For Majority line: For
28 Apr 2026Generalised scheme of tariff preferences Passed 459 for, 127 against, 70 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Welfare of dogs and cats and their traceability Passed 558 for, 35 against, 52 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Amendments to Biocidal Products Regulation as regards the extension of certain data protection periods Passed 591 for, 54 against, 8 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026European Globalisation Adjustment Fund: workers affected by imminent job displacement Passed 566 for, 67 against, 26 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Interim report on the proposal for the multiannual financial framework for 2028-2034 Interim report adopted 370 for, 201 against, 84 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Guidelines for the 2027 budget - Section III Adopted 389 for, 191 against, 75 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Amendments to Parliament's Rules of Procedure concerning appointments to Union agencies and bodies (Rule 135) Adopted 657 for, 0 against, 3 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Control of the financial activities of the European Investment Bank Group – annual report 2024 Adopted 377 for, 254 against, 31 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Importance of consent-based rape legislation in the EU Adopted 447 for, 160 against, 43 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Protection of the European Union’s financial interests – combating fraud – annual report 2024 Rejected 231 for, 389 against, 33 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026The role of ocean diplomacy for the competitiveness of EU fisheries and aquaculture Adopted 430 for, 107 against, 115 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Control, transparency and traceability of performance-based instruments Adopted 527 for, 85 against, 33 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Enhancing connectivity, preserving cultural heritage and driving local excellence in European tourism – destination management and regional tourism growth Adopted 439 for, 42 against, 129 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Extension of the term of office of the Special Committee on the European Democracy Shield Adopted 422 for, 202 against, 9 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Common system for the return of third-country nationals staying illegally in the Union (Return Regulation) Negotiating mandate approved 389 for, 206 against, 32 abstainedPosition: For Majority line: For
26 Mar 2026Combating corruption Passed 581 for, 21 against, 42 abstainedPosition: For Majority line: For
26 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Failed 228 for, 311 against, 92 abstainedPosition: For ≠ groupMajority line: Against
26 Mar 2026Adjustment of customs duties and opening of tariff quotas for the import of certain goods originating in the United States of America Passed 417 for, 154 against, 71 abstainedPosition: For Majority line: For
26 Mar 2026Non-application of customs duties on imports of certain goods Passed 437 for, 144 against, 60 abstainedPosition: For Majority line: For
26 Mar 2026Simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI) Passed 569 for, 45 against, 23 abstainedPosition: For Majority line: For
26 Mar 2026United Nations Convention on the International Effects of Judicial Sales of Ships Consent given 605 for, 3 against, 9 abstainedPosition: For Majority line: For
26 Mar 2026EU-China Agreement: modification of concessions on all the tariff rate quotas included in the EU Schedule CLXXV Consent given 603 for, 3 against, 33 abstainedPosition: For Majority line: For
26 Mar 2026EU-Lebanon Agreement for scientific and technological cooperation setting, participation of Lebanon in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) Consent given 618 for, 6 against, 5 abstainedPosition: For Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/005 AT/KTM - Austria Passed 584 for, 39 against, 13 abstainedPosition: For Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/007 BE/Casa - Belgium Passed 575 for, 48 against, 10 abstainedPosition: For Majority line: For
26 Mar 2026Union framework for the national calculation of life-cycle global warming potential Objection failed 208 for, 414 against, 10 abstainedPosition: Against Majority line: Against
26 Mar 2026Global Gateway – past impacts and future orientation Adopted 371 for, 146 against, 80 abstainedPosition: For Majority line: For
12 Mar 2026Calculation of emission credits for heavy-duty vehicles for the reporting periods of the years 2025 to 2029 Passed 473 for, 81 against, 9 abstainedPosition: No vote recorded Majority line: For
12 Mar 2026Package travel and linked travel arrangements: make the protection of travellers more effective and simplify and clarify certain aspects Passed 537 for, 2 against, 24 abstainedPosition: No vote recorded Majority line: For
12 Mar 2026Human trafficking and grave human rights violations linked to the recruitment of non-Russian nationals, in particular from Africa, for Russia’s war of aggression in Ukraine Adopted 479 for, 17 against, 43 abstainedPosition: No vote recorded Majority line: For
12 Mar 2026The arbitrary detention of President Mohamed Bazoum by the junta in Niger Adopted 524 for, 2 against, 29 abstainedPosition: No vote recorded Majority line: For
12 Mar 2026Case of Elene Khoshtaria and political prisoners under the Georgian Dream regime Adopted 438 for, 37 against, 81 abstainedPosition: No vote recorded Majority line: For
12 Mar 2026Activities of the European Ombudsman – annual report 2024 Rejected 233 for, 250 against, 76 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Passed 458 for, 103 against, 63 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Council of Europe Framework Convention on Artificial Intelligence and Human Rights, Democracy and the Rule of Law Consent given 455 for, 101 against, 74 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026EU-Ecuador Agreement: cooperation between Europol and the Ecuadorian authorities competent for combating serious crime and terrorism Consent given 586 for, 21 against, 11 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/004 BE/Tupperware – Belgium Passed 562 for, 53 against, 19 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Framework Agreement on relations between the European Parliament and the European Commission Adopted 446 for, 100 against, 72 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Gender pay and pension gap in the EU: state of play, challenges and the way forward, and developing guidelines for the better evaluation and fairer remuneration of work in female-dominated sectors Adopted 458 for, 72 against, 98 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026European Semester for economic policy coordination 2026 Adopted 392 for, 219 against, 18 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026European Semester for economic policy coordination: employment and social priorities for 2026 Adopted 404 for, 208 against, 20 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026EU enlargement strategy Adopted 385 for, 147 against, 98 abstainedPosition: No vote recorded Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 19 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Krzysztof HETMAN EPPPoland96 % of 4 016 shared89 %
Jacek PROTAS EPPPoland95 % of 4 257 shared89 %
Marta WCISŁO EPPPoland95 % of 4 353 shared89 %
Bogdan Andrzej ZDROJEWSKI EPPPoland95 % of 4 363 shared89 %
Andrzej BUŁA EPPPoland95 % of 4 003 shared89 %
Kamila GASIUK-PIHOWICZ EPPPoland94 % of 4 317 shared89 %
Dariusz JOŃSKI EPPPoland94 % of 4 334 shared89 %
Bartosz ARŁUKOWICZ EPPPoland94 % of 4 178 shared89 %
Andrzej HALICKI EPPPoland94 % of 4 105 shared89 %
Bartłomiej SIENKIEWICZ EPPPoland94 % of 4 317 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Eugen TOMAC RenewRomania81 % of 3 166 shared82 %
Katri KULMUNI RenewFinland81 % of 3 539 shared82 %
Urmas PAET RenewEstonia81 % of 3 836 shared82 %
Dan BARNA RenewRomania80 % of 3 840 shared82 %
Hilde VAUTMANS RenewBelgium80 % of 4 231 shared82 %
Marie-Pierre VEDRENNE Former memberRenewFrance80 % of 1 976 shared82 %
Bart GROOTHUIS RenewNetherlands79 % of 3 307 shared82 %
Jeannette BALJEU RenewNetherlands79 % of 3 942 shared82 %
Ivars IJABS RenewLatvia79 % of 3 424 shared82 %
Benoit CASSART RenewBelgium79 % of 4 014 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeChair29 Jan 2025now
Delegation for relations with the People's Republic of ChinaD-CN DelegationMember19 Sept 2024now
Delegation for relations with the Korean PeninsulaDKOR DelegationSubstitute19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeSubstitute19 Jul 202419 Jan 2025
Committee on Public HealthSANT CommitteeMember23 Jan 202528 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeChair23 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202422 Jul 2024

Show all 10 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
EU Emissions Trading System: heat and fuel benchmark values for 2026–2030RapporteurENVI2 Sept 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsRapporteurSANT16 Apr 2026
24th EU-Republic of South Korea Interparliamentary Meeting\nSeoul 27-29 May 2026Official delegationDKOR16 Apr 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI16 Apr 2026
No dossier namedOfficial delegationSANT24 Mar 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI24 Mar 2026
Laying down the multiannual financial framework for the years 2028 to 2034Opinion rapporteurSANT11 Feb 2026
Guidelines for the 2027 Budget - Section IIIOpinion rapporteurSANT11 Feb 2026
No dossier namedOfficial delegationSANT28 Jan 2026
No dossier namedOfficial delegationSANT9 Oct 2025

Show all 14 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

14 contributions recorded; 2 on behalf of their group; 23 minutes of speaking time.

Show all 14 recent contributions

Questions and motions, 29

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
22 Jun 2026SCoPAFF’s reclassification of plant protection products E-10-2026-002564Written questionwith 1 co-authorNot yet answered
17 Jun 2026Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516Written questionwith 17 co-authors24 Aug 2026
25 Mar 2026Ensuring competition and strategic autonomy in the AI gigafactory supply chain E-10-2026-001255Written questionwith 17 co-authors19 Jun 2026
24 Feb 2026Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762Written questionwith 20 co-authors16 Apr 2026
18 Feb 2026Inspections to ensure regulatory conformity of cosmetic products in the single market with the Cosmetic Products Regulation E-10-2026-000687Written questionwith 22 co-authorsNot yet answered
18 Feb 2026Checks on the presence of prohibited substances and trace impurities in non-EU cosmetic products entering the single market E-10-2026-000688Written questionwith 21 co-authors21 May 2026
13 Feb 2026Commission proceedings concerning complaint CPLT(2023)02625 on Poland’s restrictions on pharmacy ownership E-10-2026-000645Written questionwith 2 co-authors26 Mar 2026
11 Feb 2026Protecting allergic consumers by harmonising EU ingredient labelling E-10-2026-000591Written questionwith 5 co-authors17 Apr 2026
9 Feb 2026MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141Motion for a resolutionwith 18 co-authors—
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026

Show all 29 questions and motions

Amendments tabled in committee, 114

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT35
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT5
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT8
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791073 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791874 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791873 CJ7219
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ537
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ538

Show all 114 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Adam JARUBAS”. Member record. memberId 197517. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197517?page=4&scope=final&vscope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197517?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197517,
  author = {{EU Parl Watch Research}},
  title = {{Adam JARUBAS}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197517?page=4&scope=final&vscope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/197517?page=4&scope=final&vscope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197517. Official source: https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}